MM-310-01-01-01: A Phase 1 Study Evaluating the Safety, Pharmacology and Preliminary Activity of MM-310 in Patients with Solid Tumors
Clinical Trial Grant
Awarded By
Merrimack Pharmaceuticals
Start Date
October 26, 2017
End Date
April 1, 2020
Awarded By
Merrimack Pharmaceuticals
Start Date
October 26, 2017
End Date
April 1, 2020